In this study, published in ERJ Open Research, oral prednisone did not show any advantage in patients with COPD exacerbation in primary care. Significantly higher respiratory-related treatment failure in the prednisone group warns against the use of corticosteroids in this setting. https://openres.ersjournals.com/content/9/5/00057-2023
No comments:
Post a Comment